Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2024-09-13 16:30 Tx date 2024-09-13 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$56,400
+600,000 vol $0.094 each |
1,926,860 | |
Filed 2024-08-14 13:23 Tx date 2024-08-14 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,207
+49,500 vol $0.085 each |
1,546,284 | |
Filed 2024-07-18 15:27 Tx date 2024-07-18 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+150,000 vol |
697,630 | |
Filed 2024-07-18 15:25 Tx date 2024-07-18 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$30,000
+300,000 vol $0.10 each |
1,496,784 | |
Filed 2024-07-15 16:27 Tx date 2024-07-03 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
$6,881
+63,951 vol $0.1076 each |
1,196,784 | |
Filed 2024-05-18 19:12 Tx date 2024-05-16 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Performance Share Units
57 - Exercise of rights
|
-38,834 vol |
137,455 | |
Filed 2024-05-18 19:10 Tx date 2024-05-16 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Performance Share Units
58 - Expiration of rights
|
-38,834 vol |
176,289 | |
Filed 2024-05-18 19:07 Tx date 2024-05-16 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$3,689
+38,834 vol $0.095 each |
1,132,833 | |
Filed 2024-04-15 11:25 Tx date 2024-04-12 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-345,000 vol |
547,630 | |
Filed 2024-04-02 17:13 Tx date 2024-04-02 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-37,163 vol |
537,161 | |
Filed 2024-04-02 17:10 Tx date 2024-04-02 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$3,530
+37,163 vol $0.095 each |
1,093,999 | |
Filed 2024-01-02 15:56 Tx date 2023-12-29 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$3,100
+27,855 vol $0.1113 each |
1,056,836 | |
Filed 2023-11-30 18:07 Tx date 2023-11-28 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+500,000 vol |
574,324 | |
Filed 2023-11-30 18:05 Tx date 2023-11-28 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,000,000 vol |
1,326,860 | |
Filed 2023-10-12 15:54 Tx date 2023-10-10 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+547,630 vol |
892,630 | |
Filed 2023-10-12 12:20 Tx date 2023-10-10 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures 12% Unsecured Convertible Debenture
16 - Acquisition or disposition under a prospectus exemption
|
$
+$115 vol $1,000 each |
$115 | |
Filed 2023-10-12 12:19 Tx date 2019-04-12 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures 12% Unsecured Convertible Debenture
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2023-05-01 11:55 Tx date 2023-04-28 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$3,368
+25,910 vol $0.13 each |
1,028,981 | |
Filed 2023-05-01 11:52 Tx date 2023-04-28 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Performance Share Units
57 - Exercise of rights
|
-25,910 vol |
215,123 | |
Filed 2023-04-13 14:11 Tx date 2023-04-13 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,400
+40,000 vol $0.11 each |
1,003,071 | |
Filed 2023-03-31 12:40 Tx date 2023-03-30 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+37,162 vol |
963,071 | |
Filed 2023-03-31 12:39 Tx date 2023-03-30 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
36 - Conversion or exchange
|
-37,162 vol |
74,324 | |
Filed 2023-03-31 12:31 Tx date 2023-03-30 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
$-721,700
-412,400 vol $1.75 each |
326,860 | |
Filed 2022-08-25 14:09 Tx date 2022-08-25 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$22,000
+200,000 vol $0.11 each |
925,909 | |
Filed 2022-05-05 10:03 Tx date 2022-05-02 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+25,909 vol |
725,909 | |
Filed 2022-05-05 10:00 Tx date 2022-05-02 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Performance Share Units
57 - Exercise of rights
|
-25,909 vol |
241,033 | |
Filed 2022-04-25 11:40 Tx date 2022-04-20 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+111,486 vol |
111,486 | |
Filed 2022-04-25 11:39 Tx date 2019-04-12 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-04-25 11:37 Tx date 2022-04-20 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Performance Share Units
56 - Grant of rights
|
+111,486 vol |
266,942 | |
Filed 2022-04-25 11:28 Tx date 2022-04-20 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$18,430
+50,000 vol $0.3686 each |
839,260 | |
Filed 2022-04-25 11:20 Tx date 2022-04-22 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-175,000
-100,000 vol $1.75 each |
739,260 | |
Filed 2021-10-18 14:14 Tx date 2021-10-18 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,162
+7,853 vol $0.53 each |
700,000 | |
Filed 2021-10-15 16:05 Tx date 2021-10-15 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,590
+3,000 vol $0.53 each |
692,147 | |
Filed 2021-08-31 11:50 Tx date 2021-08-31 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,830
+7,000 vol $0.69 each |
689,147 | |
Filed 2021-08-11 16:49 Tx date 2021-08-11 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,555
+3,500 vol $0.73 each |
682,147 | |
Filed 2021-05-03 18:47 Tx date 2021-04-28 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Performance Share Units
30 - Acquisition or disposition under a purchase/ownership plan
|
+155,456 vol |
155,456 | |
Filed 2021-05-03 18:46 Tx date 2019-04-12 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-05-03 17:19 Tx date 2021-04-28 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$322,000
+200,000 vol $1.61 each |
789,260 | |
Filed 2021-02-26 11:03 Tx date 2021-02-26 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$65,376
+76,913 vol $0.85 each |
678,647 | |
Filed 2021-02-26 11:00 Tx date 2021-02-26 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-65,376.05
-76,913 vol $0.85 each |
345,000 | |
Filed 2020-10-30 18:48 Tx date 2020-10-29 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$4,614
+76,913 vol $0.06 each |
421,913 | |
Filed 2020-10-30 18:44 Tx date 2020-10-29 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$95,372
+153,826 vol $0.62 each |
601,734 | |
Filed 2020-07-14 17:27 Tx date 2020-07-14 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,880
+4,000 vol $0.47 each |
447,908 | |
Filed 2020-07-13 10:12 Tx date 2020-07-10 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$250.00
+500 vol $0.50 each |
443,908 | |
Filed 2020-06-10 17:21 Tx date 2020-06-04 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$31,512
+76,860 vol $0.41 each |
589,260 | |
Filed 2020-06-10 17:16 Tx date 2020-06-10 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$36,500
+100,000 vol $0.365 each |
443,408 | |
Filed 2020-06-04 16:10 Tx date 2020-06-04 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,000
+25,000 vol $0.40 each |
343,408 | |
Filed 2020-02-21 09:35 Tx date 2020-02-20 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$17,000
+25,000 vol $0.68 each |
318,408 | |
Filed 2019-11-06 11:37 Tx date 2019-11-05 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$13,600
+20,000 vol $0.68 each |
293,408 | |
Filed 2019-10-21 12:00 Tx date 2019-10-18 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,450
+15,000 vol $0.63 each |
273,408 | |
Filed 2019-10-07 17:19 Tx date 2019-10-07 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
$65,250
+145,000 vol $0.45 each |
345,000 | |
Filed 2019-08-02 13:00 Tx date 2019-05-17 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
37 - Stock split or consolidation
|
-4,800,000 vol |
200,000 | |
Filed 2019-08-02 12:59 Tx date 2019-05-17 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-12,297,600 vol |
512,400 | |
Filed 2019-08-02 12:57 Tx date 2019-05-17 |
$WLLW
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-6,201,792 vol |
258,408 | |
Filed 2019-06-27 17:28 Tx date 2019-06-26 |
$MKNA
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$24,400
+20,000 vol $1.22 each |
||
Filed 2019-06-27 15:04 Tx date 2019-06-26 |
$MKNA
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$24,400
+20,000 vol $1.22 each |
||
Filed 2019-06-27 15:04 Tx date 2019-06-26 |
$MKNA
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$24,400
+20,000 vol $1.22 each |
6,480,200 | |
Filed 2019-05-10 12:27 Tx date 2019-05-02 |
$MKNA
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+12,810,000 vol |
12,810,000 | |
Filed 2019-05-10 12:13 Tx date 2019-05-02 |
$MKNA
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+12,810,000 vol |
||
Filed 2019-05-10 12:09 Tx date 2019-04-12 |
$MKNA
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-04-23 14:21 Tx date 2019-04-12 |
$MKNA
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+1,460,200 vol |
6,460,200 | |
Filed 2019-04-22 18:12 Tx date 2019-04-12 |
$MKNA
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
5,000,000 | ||
Filed 2019-04-22 18:12 Tx date 2019-04-12 |
$MKNA
Willow Biosciences Inc. |
Doupe, Travis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
5,000,000 |